SCHEMBL3976993

SCHEMBL3976993

N#Cc1c(O)ccc(C(=O)OC(=O)c2occ(-c3ccc(Cl)cc3)c2-c2ccc(Cl)cc2)c1C(=O)NN

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 2/20 0.35
KMT2A Q03164 4/20 0.34
LMNA P02545 1/20 0.34
PIK3CA P42336 2/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
MEN1 O00255 2/20 0.33
RECQL P46063 1/20 0.33
HIF1A Q16665 1/20 0.33
GAA P10253 2/20 0.32
MAPT P10636 2/20 0.32
POLB P06746 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PIM1 P11309 1/20 0.32
TLR9 Q9NR96 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975288 0.91 KDM4E (0.33) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL3974992 0.91 CA12 (0.31) MAPT
SCHEMBL3975937 0.91 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDKMT2ALMNA
SCHEMBL3979485 0.86 MAPT (0.41) ALDH1A1KDM4EHPGDKMT2ALMNA
SCHEMBL3977604 0.86 ALDH1A1 (0.33) ALDH1A1HPGDGAAMAPTPOLB
SCHEMBL3978288 0.82 ALDH1A1 (0.34) ALDH1A1KDM4EHPGDKMT2ALMNA
SCHEMBL3982135 0.81 MEN1 (0.34) ALDH1A1KDM4EHPGDKMT2ALMNA
SCHEMBL3985231 0.81 ALDH1A1 (0.34) ALDH1A1HPGDALOX15ALOX12GAA
SCHEMBL3974971 0.80 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDKMT2ALMNA
SCHEMBL3977121 0.79 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 ALDH1A1 1389/4885KDM4E 2769/4885HPGD 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.